Rank | Gene Set | Z-score |
---|---|---|
1 | Golgi transport vesicle coating (GO:0048200) | 6.55433949 |
2 | COPI coating of Golgi vesicle (GO:0048205) | 6.55433949 |
3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.31258064 |
4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.31258064 |
5 | antigen processing and presentation via MHC class Ib (GO:0002475) | 5.89141131 |
6 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.53858835 |
7 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.40450227 |
8 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.34212731 |
9 | DNA deamination (GO:0045006) | 4.02962804 |
10 | negative regulation of cell size (GO:0045792) | 4.01086254 |
11 | thymic T cell selection (GO:0045061) | 3.99508549 |
12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.72623042 |
13 | sodium ion export (GO:0071436) | 3.60259001 |
14 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.57530578 |
15 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 3.52162834 |
16 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.50440276 |
17 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.49067135 |
18 | positive regulation of nuclease activity (GO:0032075) | 3.47181754 |
19 | pentose-phosphate shunt (GO:0006098) | 3.41247910 |
20 | regulation of early endosome to late endosome transport (GO:2000641) | 3.32825283 |
21 | protein maturation by protein folding (GO:0022417) | 3.28364366 |
22 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.27695319 |
23 | negative regulation of cell killing (GO:0031342) | 3.27695319 |
24 | apoptotic process involved in morphogenesis (GO:0060561) | 3.26645085 |
25 | detection of bacterium (GO:0016045) | 3.25361557 |
26 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 3.24979286 |
27 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.24330228 |
28 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.22080801 |
29 | synaptic vesicle maturation (GO:0016188) | 3.19510688 |
30 | T cell selection (GO:0045058) | 3.19296637 |
31 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.17393733 |
32 | protein retention in ER lumen (GO:0006621) | 3.16928881 |
33 | regulation of gamma-delta T cell activation (GO:0046643) | 3.15580699 |
34 | regulation of translational termination (GO:0006449) | 3.14185059 |
35 | regulation of protein heterodimerization activity (GO:0043497) | 3.12468113 |
36 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.12041823 |
37 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.10190337 |
38 | regulation of nuclease activity (GO:0032069) | 3.09998244 |
39 | modulation by virus of host process (GO:0019054) | 3.09820504 |
40 | positive T cell selection (GO:0043368) | 3.05892608 |
41 | tricarboxylic acid metabolic process (GO:0072350) | 3.05037368 |
42 | positive regulation by symbiont of host defense response (GO:0052509) | 3.04932599 |
43 | modulation by symbiont of host defense response (GO:0052031) | 3.04932599 |
44 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.04932599 |
45 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.04932599 |
46 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.04932599 |
47 | modulation by symbiont of host immune response (GO:0052553) | 3.04932599 |
48 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.02470113 |
49 | detection of other organism (GO:0098543) | 3.02124468 |
50 | natural killer cell differentiation (GO:0001779) | 2.98505500 |
51 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.93950525 |
52 | modulation by symbiont of host cellular process (GO:0044068) | 2.93205191 |
53 | NADPH regeneration (GO:0006740) | 2.92538194 |
54 | B cell receptor signaling pathway (GO:0050853) | 2.91981434 |
55 | negative thymic T cell selection (GO:0045060) | 2.87702809 |
56 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.85692023 |
57 | regulation of defense response to virus by virus (GO:0050690) | 2.83532207 |
58 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.80976110 |
59 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.79980894 |
60 | response to laminar fluid shear stress (GO:0034616) | 2.79051136 |
61 | positive regulation of histone deacetylation (GO:0031065) | 2.78166947 |
62 | regulation of extracellular matrix disassembly (GO:0010715) | 2.76897173 |
63 | regulation of translational fidelity (GO:0006450) | 2.75978052 |
64 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.75932324 |
65 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.75466754 |
66 | vesicle coating (GO:0006901) | 2.72829791 |
67 | negative regulation of microtubule polymerization (GO:0031115) | 2.72422112 |
68 | response to muramyl dipeptide (GO:0032495) | 2.71475246 |
69 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.71306446 |
70 | barbed-end actin filament capping (GO:0051016) | 2.69700231 |
71 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.69337340 |
72 | signal complex assembly (GO:0007172) | 2.68494986 |
73 | positive regulation of Rap GTPase activity (GO:0032854) | 2.67891265 |
74 | regulation of ARF GTPase activity (GO:0032312) | 2.66633891 |
75 | negative regulation of myotube differentiation (GO:0010832) | 2.66400982 |
76 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.65768490 |
77 | beta-amyloid metabolic process (GO:0050435) | 2.65350201 |
78 | negative regulation of phagocytosis (GO:0050765) | 2.65341408 |
79 | activation of JUN kinase activity (GO:0007257) | 2.65012744 |
80 | cellular response to topologically incorrect protein (GO:0035967) | 2.64804955 |
81 | regulation of erythrocyte differentiation (GO:0045646) | 2.63875761 |
82 | ribosomal small subunit assembly (GO:0000028) | 2.63415341 |
83 | negative T cell selection (GO:0043383) | 2.63408755 |
84 | positive regulation of protein deacetylation (GO:0090312) | 2.62482428 |
85 | cellular response to unfolded protein (GO:0034620) | 2.62378516 |
86 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.62169247 |
87 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.61540604 |
88 | Peyers patch development (GO:0048541) | 2.61540604 |
89 | negative regulation of viral release from host cell (GO:1902187) | 2.61367563 |
90 | purine-containing compound salvage (GO:0043101) | 2.61075927 |
91 | galactose catabolic process (GO:0019388) | 2.59579539 |
92 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.59247206 |
93 | actin nucleation (GO:0045010) | 2.58625855 |
94 | serine transport (GO:0032329) | 2.58161169 |
95 | negative regulation of innate immune response (GO:0045824) | 2.57951836 |
96 | embryonic process involved in female pregnancy (GO:0060136) | 2.57660239 |
97 | regulation of chromatin binding (GO:0035561) | 2.57228276 |
98 | activation of MAPKKK activity (GO:0000185) | 2.56343430 |
99 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.55590808 |
100 | ER-nucleus signaling pathway (GO:0006984) | 2.54799436 |
101 | regulation of cholesterol homeostasis (GO:2000188) | 2.54723760 |
102 | regulation of autophagic vacuole assembly (GO:2000785) | 2.54613653 |
103 | response to pheromone (GO:0019236) | 2.53441061 |
104 | regulation of necrotic cell death (GO:0010939) | 2.53231629 |
105 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.52402203 |
106 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.52074662 |
107 | negative regulation of necroptotic process (GO:0060546) | 2.52074560 |
108 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.52008323 |
109 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.50840154 |
110 | NADH metabolic process (GO:0006734) | 2.50260434 |
111 | cerebellar Purkinje cell layer development (GO:0021680) | 2.50153980 |
112 | activation of Rac GTPase activity (GO:0032863) | 2.50111716 |
113 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.49888788 |
114 | virion assembly (GO:0019068) | 2.48802064 |
115 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.48410670 |
116 | peptidyl-lysine dimethylation (GO:0018027) | 2.48064178 |
117 | adaptation of signaling pathway (GO:0023058) | 2.47838151 |
118 | histone H3-K36 demethylation (GO:0070544) | 2.46907951 |
119 | execution phase of apoptosis (GO:0097194) | 2.46503821 |
120 | ribosomal small subunit biogenesis (GO:0042274) | 2.46138225 |
121 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.45939260 |
122 | focal adhesion assembly (GO:0048041) | 2.45646555 |
123 | cell-substrate adherens junction assembly (GO:0007045) | 2.45646555 |
124 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.45475976 |
125 | regulation of leukocyte degranulation (GO:0043300) | 2.44336934 |
126 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.43809838 |
127 | regulation of synapse structural plasticity (GO:0051823) | 2.43521657 |
128 | positive regulation of synapse maturation (GO:0090129) | 2.42335915 |
129 | maternal placenta development (GO:0001893) | 2.42297273 |
130 | positive thymic T cell selection (GO:0045059) | 2.41935053 |
131 | adherens junction assembly (GO:0034333) | 2.41593518 |
132 | positive regulation of B cell differentiation (GO:0045579) | 2.41008630 |
133 | response to interleukin-4 (GO:0070670) | 2.40705239 |
134 | mannose metabolic process (GO:0006013) | 2.40264533 |
135 | cellular response to interleukin-4 (GO:0071353) | 2.40051733 |
136 | leukocyte aggregation (GO:0070486) | 2.39810826 |
137 | cell communication by electrical coupling (GO:0010644) | 2.38757588 |
138 | response to peptidoglycan (GO:0032494) | 2.38657814 |
139 | negative regulation of TOR signaling (GO:0032007) | 2.38483069 |
140 | immunoglobulin mediated immune response (GO:0016064) | 2.38447745 |
141 | N-glycan processing (GO:0006491) | 2.37917140 |
142 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.37911693 |
143 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.37884948 |
144 | negative regulation of glial cell proliferation (GO:0060253) | 2.36772457 |
145 | regulation of necroptotic process (GO:0060544) | 2.35563436 |
146 | cellular response to virus (GO:0098586) | 2.35242107 |
147 | regulation of B cell differentiation (GO:0045577) | 2.34873864 |
148 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.34859318 |
149 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.33941534 |
150 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.33580516 |
151 | NIK/NF-kappaB signaling (GO:0038061) | 2.33294429 |
152 | GDP-mannose metabolic process (GO:0019673) | 2.32330293 |
153 | glucose catabolic process (GO:0006007) | 2.32220362 |
154 | positive regulation of insulin secretion (GO:0032024) | 2.32078399 |
155 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.32014813 |
156 | positive regulation of lamellipodium assembly (GO:0010592) | 2.31572425 |
157 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.30246842 |
158 | viral transcription (GO:0019083) | 2.29072650 |
159 | pyrimidine nucleoside salvage (GO:0043097) | 2.28868511 |
160 | pyrimidine-containing compound salvage (GO:0008655) | 2.28868511 |
161 | regulation of ARF protein signal transduction (GO:0032012) | 2.28790966 |
162 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.28728633 |
163 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.27152639 |
164 | protein localization to endosome (GO:0036010) | 2.25814463 |
165 | actin filament polymerization (GO:0030041) | 2.25338018 |
166 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.23738542 |
167 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.22650398 |
168 | negative regulation of fatty acid transport (GO:2000192) | 2.22499654 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MYC_22102868_ChIP-Seq_BL_Human | 3.52537278 |
2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.18922408 |
3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.01189750 |
4 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.73554145 |
5 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.33765731 |
6 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.14303935 |
7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.11838657 |
8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.11152140 |
9 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.09893547 |
10 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.02950297 |
11 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.97605953 |
12 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.94104688 |
13 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.93986757 |
14 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.93565199 |
15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92989091 |
16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.92093771 |
17 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.91686500 |
18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.89235795 |
19 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.88377996 |
20 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.85974914 |
21 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.83972029 |
22 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.83319575 |
23 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.82971443 |
24 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78583734 |
25 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.70133827 |
26 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.69001302 |
27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.67991919 |
28 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.66777945 |
29 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.65021595 |
30 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.64123314 |
31 | UTX_26944678_Chip-Seq_JUKART_Human | 1.63566369 |
32 | MAF_26560356_Chip-Seq_TH1_Human | 1.62481654 |
33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.62466818 |
34 | P68_20966046_ChIP-Seq_HELA_Human | 1.62006911 |
35 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.59021633 |
36 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.57747778 |
37 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.57584917 |
38 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.57503019 |
39 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.56757371 |
40 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.56638827 |
41 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.56540176 |
42 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.53794876 |
43 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.53658533 |
44 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.52414223 |
45 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49915767 |
46 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.47883213 |
47 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.46970885 |
48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.41506114 |
49 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.40380145 |
50 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.40278110 |
51 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.40200295 |
52 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.38050148 |
53 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.37935475 |
54 | SPI1_23127762_ChIP-Seq_K562_Human | 1.36521438 |
55 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.35185950 |
56 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.34961565 |
57 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.33857012 |
58 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.33701835 |
59 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.31776299 |
60 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.31017474 |
61 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.30964985 |
62 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.30291859 |
63 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.29881411 |
64 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.29528032 |
65 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.27918360 |
66 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.27333107 |
67 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.27114594 |
68 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.26865502 |
69 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.26713752 |
70 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26175710 |
71 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.25948288 |
72 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.25764310 |
73 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.25643200 |
74 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24163147 |
75 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.23669889 |
76 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.23288192 |
77 | MAF_26560356_Chip-Seq_TH2_Human | 1.23127734 |
78 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.21350403 |
79 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.19491170 |
80 | KDM2B_26808549_Chip-Seq_K562_Human | 1.18594087 |
81 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.17491646 |
82 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.17471747 |
83 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16844671 |
84 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.16648165 |
85 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.16384201 |
86 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.16327383 |
87 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.15944006 |
88 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14716146 |
89 | MYB_26560356_Chip-Seq_TH2_Human | 1.14597445 |
90 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.14516195 |
91 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.14117622 |
92 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14054293 |
93 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.13989375 |
94 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.13484915 |
95 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13249639 |
96 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.12984747 |
97 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.12857430 |
98 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.11404919 |
99 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.11387617 |
100 | ATF3_27146783_Chip-Seq_COLON_Human | 1.11104980 |
101 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.10737001 |
102 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.10270520 |
103 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.10187086 |
104 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.10123590 |
105 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.09631410 |
106 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.08632520 |
107 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.08586816 |
108 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.07648372 |
109 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.07106903 |
110 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.07065866 |
111 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.06850041 |
112 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.06584343 |
113 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.06457031 |
114 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.06029248 |
115 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.05037976 |
116 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04600099 |
117 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.04125698 |
118 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03856855 |
119 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.03538064 |
120 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.03300805 |
121 | SA1_27219007_Chip-Seq_Bcells_Human | 1.02392776 |
122 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02348696 |
123 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.02292319 |
124 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.02211604 |
125 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.01915958 |
126 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.01865873 |
127 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.01793732 |
128 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.01291535 |
129 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.00163932 |
130 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99749299 |
131 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.99141647 |
132 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.99112047 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005451_abnormal_body_composition | 3.42866737 |
2 | MP0003172_abnormal_lysosome_physiology | 3.01273124 |
3 | MP0002653_abnormal_ependyma_morphology | 3.00304567 |
4 | MP0009840_abnormal_foam_cell | 2.87558210 |
5 | MP0000685_abnormal_immune_system | 2.82521566 |
6 | MP0002909_abnormal_adrenal_gland | 2.69324366 |
7 | MP0003183_abnormal_peptide_metabolism | 2.66964500 |
8 | MP0008961_abnormal_basal_metabolism | 2.64516159 |
9 | MP0003329_amyloid_beta_deposits | 2.41147227 |
10 | MP0004859_abnormal_synaptic_plasticity | 2.31767792 |
11 | MP0001835_abnormal_antigen_presentation | 2.25271712 |
12 | MP0008260_abnormal_autophagy | 2.21399166 |
13 | MP0004858_abnormal_nervous_system | 2.20370947 |
14 | MP0003303_peritoneal_inflammation | 2.14084000 |
15 | MP0010234_abnormal_vibrissa_follicle | 2.13488378 |
16 | MP0003436_decreased_susceptibility_to | 2.02296735 |
17 | MP0000604_amyloidosis | 1.99969884 |
18 | MP0003300_gastrointestinal_ulcer | 1.95819191 |
19 | MP0002396_abnormal_hematopoietic_system | 1.87733219 |
20 | MP0001545_abnormal_hematopoietic_system | 1.85308099 |
21 | MP0005397_hematopoietic_system_phenotyp | 1.85308099 |
22 | MP0005058_abnormal_lysosome_morphology | 1.84305153 |
23 | MP0002877_abnormal_melanocyte_morpholog | 1.83453464 |
24 | MP0003866_abnormal_defecation | 1.82683958 |
25 | MP0004185_abnormal_adipocyte_glucose | 1.82186953 |
26 | MP0005360_urolithiasis | 1.81063845 |
27 | MP0003283_abnormal_digestive_organ | 1.77961416 |
28 | MP0002796_impaired_skin_barrier | 1.77766871 |
29 | MP0005666_abnormal_adipose_tissue | 1.68172878 |
30 | MP0000013_abnormal_adipose_tissue | 1.65899669 |
31 | MP0004947_skin_inflammation | 1.64417085 |
32 | MP0003763_abnormal_thymus_physiology | 1.62665117 |
33 | MP0002398_abnormal_bone_marrow | 1.61582345 |
34 | MP0003656_abnormal_erythrocyte_physiolo | 1.57180503 |
35 | MP0010352_gastrointestinal_tract_polyps | 1.56983930 |
36 | MP0009278_abnormal_bone_marrow | 1.53007564 |
37 | MP0001348_abnormal_lacrimal_gland | 1.52188344 |
38 | MP0001790_abnormal_immune_system | 1.51652690 |
39 | MP0005387_immune_system_phenotype | 1.51652690 |
40 | MP0002693_abnormal_pancreas_physiology | 1.51192878 |
41 | MP0005310_abnormal_salivary_gland | 1.50348686 |
42 | MP0005076_abnormal_cell_differentiation | 1.50294145 |
43 | MP0002009_preneoplasia | 1.50224685 |
44 | MP0004381_abnormal_hair_follicle | 1.48307600 |
45 | MP0003453_abnormal_keratinocyte_physiol | 1.46673304 |
46 | MP0001819_abnormal_immune_cell | 1.45969911 |
47 | MP0002420_abnormal_adaptive_immunity | 1.45337455 |
48 | MP0001800_abnormal_humoral_immune | 1.43888046 |
49 | MP0005000_abnormal_immune_tolerance | 1.43346183 |
50 | MP0002723_abnormal_immune_serum | 1.40021080 |
51 | MP0004510_myositis | 1.39358028 |
52 | MP0002722_abnormal_immune_system | 1.38822606 |
53 | MP0003724_increased_susceptibility_to | 1.38395445 |
54 | MP0009333_abnormal_splenocyte_physiolog | 1.37692375 |
55 | MP0002452_abnormal_antigen_presenting | 1.35441191 |
56 | MP0000716_abnormal_immune_system | 1.33813818 |
57 | MP0000751_myopathy | 1.33652212 |
58 | MP0000703_abnormal_thymus_morphology | 1.33522267 |
59 | MP0000858_altered_metastatic_potential | 1.31283546 |
60 | MP0005464_abnormal_platelet_physiology | 1.30168430 |
61 | MP0000689_abnormal_spleen_morphology | 1.29802789 |
62 | MP0002429_abnormal_blood_cell | 1.28283495 |
63 | MP0005375_adipose_tissue_phenotype | 1.28054650 |
64 | MP0009379_abnormal_foot_pigmentation | 1.26670218 |
65 | MP0002249_abnormal_larynx_morphology | 1.25978734 |
66 | MP0000465_gastrointestinal_hemorrhage | 1.25785030 |
67 | MP0004264_abnormal_extraembryonic_tissu | 1.24994333 |
68 | MP0010155_abnormal_intestine_physiology | 1.22468297 |
69 | MP0005409_darkened_coat_color | 1.20454387 |
70 | MP0005671_abnormal_response_to | 1.19377691 |
71 | MP0000358_abnormal_cell_content/ | 1.19252835 |
72 | MP0005083_abnormal_biliary_tract | 1.18629828 |
73 | MP0001944_abnormal_pancreas_morphology | 1.18326917 |
74 | MP0004811_abnormal_neuron_physiology | 1.17060841 |
75 | MP0000490_abnormal_crypts_of | 1.16975575 |
76 | MP0005025_abnormal_response_to | 1.15938675 |
77 | MP0005501_abnormal_skin_physiology | 1.14920289 |
78 | MP0000537_abnormal_urethra_morphology | 1.13899582 |
79 | MP0002419_abnormal_innate_immunity | 1.12840114 |
80 | MP0002822_catalepsy | 1.11859347 |
81 | MP0001873_stomach_inflammation | 1.11766111 |
82 | MP0000747_muscle_weakness | 1.11578472 |
83 | MP0001533_abnormal_skeleton_physiology | 1.11307837 |
84 | MP0005670_abnormal_white_adipose | 1.11081367 |
85 | MP0003075_altered_response_to | 1.10769100 |
86 | MP0004808_abnormal_hematopoietic_stem | 1.09371030 |
87 | MP0002089_abnormal_postnatal_growth/wei | 1.08934080 |
88 | MP0002928_abnormal_bile_duct | 1.08896290 |
89 | MP0000681_abnormal_thyroid_gland | 1.08173474 |
90 | MP0003693_abnormal_embryo_hatching | 1.07820783 |
91 | MP0003191_abnormal_cellular_cholesterol | 1.07389670 |
92 | MP0002998_abnormal_bone_remodeling | 1.07167876 |
93 | MP0001845_abnormal_inflammatory_respons | 1.06912327 |
94 | MP0009785_altered_susceptibility_to | 1.00175925 |
95 | MP0002166_altered_tumor_susceptibility | 1.00063640 |
96 | MP0005220_abnormal_exocrine_pancreas | 0.99413562 |
97 | MP0003635_abnormal_synaptic_transmissio | 0.98314817 |
98 | MP0003879_abnormal_hair_cell | 0.98177612 |
99 | MP0005166_decreased_susceptibility_to | 0.97907610 |
100 | MP0002234_abnormal_pharynx_morphology | 0.94676789 |
101 | MP0008007_abnormal_cellular_replicative | 0.94391085 |
102 | MP0003091_abnormal_cell_migration | 0.94356538 |
103 | MP0003566_abnormal_cell_adhesion | 0.93967313 |
104 | MP0005645_abnormal_hypothalamus_physiol | 0.92962884 |
105 | MP0002078_abnormal_glucose_homeostasis | 0.92645808 |
106 | MP0000759_abnormal_skeletal_muscle | 0.92512520 |
107 | MP0001851_eye_inflammation | 0.91861146 |
108 | MP0010307_abnormal_tumor_latency | 0.90831255 |
109 | MP0004130_abnormal_muscle_cell | 0.90602064 |
110 | MP0005423_abnormal_somatic_nervous | 0.87846344 |
111 | MP0002138_abnormal_hepatobiliary_system | 0.87701799 |
112 | MP0002933_joint_inflammation | 0.87569984 |
113 | MP0001849_ear_inflammation | 0.87550437 |
114 | MP0002148_abnormal_hypersensitivity_rea | 0.86725842 |
115 | MP0002405_respiratory_system_inflammati | 0.86409964 |
116 | MP0001853_heart_inflammation | 0.85894784 |
117 | MP0002254_reproductive_system_inflammat | 0.85779895 |
118 | MP0008469_abnormal_protein_level | 0.85476744 |
119 | MP0009931_abnormal_skin_appearance | 0.85412151 |
120 | MP0004233_abnormal_muscle_weight | 0.85114504 |
121 | MP0000003_abnormal_adipose_tissue | 0.84981964 |
122 | MP0004957_abnormal_blastocyst_morpholog | 0.83928807 |
123 | MP0000609_abnormal_liver_physiology | 0.83033252 |
124 | MP0000313_abnormal_cell_death | 0.82567303 |
125 | MP0002269_muscular_atrophy | 0.82336252 |
126 | MP0002132_abnormal_respiratory_system | 0.79486429 |
127 | MP0000678_abnormal_parathyroid_gland | 0.78582848 |
128 | MP0000477_abnormal_intestine_morphology | 0.78429803 |
129 | MP0000733_abnormal_muscle_development | 0.78129336 |
130 | MP0001663_abnormal_digestive_system | 0.77730551 |
131 | MP0001730_embryonic_growth_arrest | 0.77711425 |
132 | MP0003279_aneurysm | 0.77135576 |
133 | MP0003705_abnormal_hypodermis_morpholog | 0.76036238 |
134 | MP0000955_abnormal_spinal_cord | 0.75786991 |
135 | MP0008874_decreased_physiological_sensi | 0.75749593 |
136 | MP0002970_abnormal_white_adipose | 0.75590134 |
137 | MP0004087_abnormal_muscle_fiber | 0.75240249 |
138 | MP0003828_pulmonary_edema | 0.75157586 |
139 | MP0005621_abnormal_cell_physiology | 0.74818066 |
140 | MP0005384_cellular_phenotype | 0.73165044 |
141 | MP0008872_abnormal_physiological_respon | 0.72166179 |
142 | MP0002080_prenatal_lethality | 0.71522608 |
143 | MP0008770_decreased_survivor_rate | 0.69285645 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Eczematoid dermatitis (HP:0000976) | 4.08048761 |
2 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.51542015 |
3 | Cellulitis (HP:0100658) | 3.50946739 |
4 | Chronic otitis media (HP:0000389) | 3.44611712 |
5 | Dysostosis multiplex (HP:0000943) | 3.22812183 |
6 | Hand muscle atrophy (HP:0009130) | 3.17725710 |
7 | Obstructive sleep apnea (HP:0002870) | 3.13501930 |
8 | Hyperacusis (HP:0010780) | 3.07661278 |
9 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.03314848 |
10 | Mucopolysacchariduria (HP:0008155) | 3.03314848 |
11 | Nasal polyposis (HP:0100582) | 3.01441099 |
12 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.97393087 |
13 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.97393087 |
14 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.97393087 |
15 | Neoplasm of the heart (HP:0100544) | 2.97171978 |
16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.94795427 |
17 | Exercise-induced myalgia (HP:0003738) | 2.93763716 |
18 | Increased cerebral lipofuscin (HP:0011813) | 2.91921486 |
19 | Abnormality of the nasal mucosa (HP:0000433) | 2.88963486 |
20 | Upper limb amyotrophy (HP:0009129) | 2.79374768 |
21 | Distal upper limb amyotrophy (HP:0007149) | 2.79374768 |
22 | Cerebral aneurysm (HP:0004944) | 2.78559597 |
23 | Microretrognathia (HP:0000308) | 2.75391889 |
24 | Abnormality of glycolipid metabolism (HP:0010969) | 2.73840462 |
25 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.73840462 |
26 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.73840462 |
27 | Myopathic facies (HP:0002058) | 2.73213807 |
28 | Insomnia (HP:0100785) | 2.67585032 |
29 | Increased variability in muscle fiber diameter (HP:0003557) | 2.64069633 |
30 | Fatigue (HP:0012378) | 2.60755834 |
31 | Hemorrhage of the eye (HP:0011885) | 2.58848524 |
32 | Visual hallucinations (HP:0002367) | 2.58153052 |
33 | Ependymoma (HP:0002888) | 2.57783957 |
34 | Distal lower limb amyotrophy (HP:0008944) | 2.54003526 |
35 | Agammaglobulinemia (HP:0004432) | 2.53808674 |
36 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.52196165 |
37 | Gastrointestinal stroma tumor (HP:0100723) | 2.51410133 |
38 | Gastrointestinal inflammation (HP:0004386) | 2.51051360 |
39 | Distal lower limb muscle weakness (HP:0009053) | 2.50716275 |
40 | Increased connective tissue (HP:0009025) | 2.50013306 |
41 | Colitis (HP:0002583) | 2.48071394 |
42 | Hypercortisolism (HP:0001578) | 2.46129624 |
43 | Pointed chin (HP:0000307) | 2.45355792 |
44 | Abnormality of the motor neurons (HP:0002450) | 2.44118225 |
45 | Abnormal neuron morphology (HP:0012757) | 2.44118225 |
46 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.43996415 |
47 | Late onset (HP:0003584) | 2.43338098 |
48 | Degeneration of anterior horn cells (HP:0002398) | 2.41736850 |
49 | Abnormality of the anterior horn cell (HP:0006802) | 2.41736850 |
50 | Deep palmar crease (HP:0006191) | 2.38441684 |
51 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.37960659 |
52 | Bulbar palsy (HP:0001283) | 2.37583646 |
53 | Obstructive lung disease (HP:0006536) | 2.34709988 |
54 | Chronic obstructive pulmonary disease (HP:0006510) | 2.34709988 |
55 | Supranuclear gaze palsy (HP:0000605) | 2.31988134 |
56 | Meningitis (HP:0001287) | 2.31400009 |
57 | Stridor (HP:0010307) | 2.29805035 |
58 | Thrombocytosis (HP:0001894) | 2.27759717 |
59 | Diminished motivation (HP:0000745) | 2.26835282 |
60 | Recurrent bronchitis (HP:0002837) | 2.26307338 |
61 | Amyotrophic lateral sclerosis (HP:0007354) | 2.25941302 |
62 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.25532199 |
63 | Hypoglycemic seizures (HP:0002173) | 2.25435740 |
64 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.25336467 |
65 | Easy fatigability (HP:0003388) | 2.24060913 |
66 | Abnormality of the fingertips (HP:0001211) | 2.23838123 |
67 | Panhypogammaglobulinemia (HP:0003139) | 2.22619108 |
68 | Loss of speech (HP:0002371) | 2.20100264 |
69 | Recurrent abscess formation (HP:0002722) | 2.19820369 |
70 | Large eyes (HP:0001090) | 2.19529816 |
71 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.19234624 |
72 | Flat acetabular roof (HP:0003180) | 2.18469271 |
73 | Mediastinal lymphadenopathy (HP:0100721) | 2.17974833 |
74 | Increased IgE level (HP:0003212) | 2.17861551 |
75 | Emphysema (HP:0002097) | 2.17211698 |
76 | Papilledema (HP:0001085) | 2.17035828 |
77 | Abnormality of T cell physiology (HP:0011840) | 2.16267857 |
78 | Spontaneous hematomas (HP:0007420) | 2.16240990 |
79 | Polygenic inheritance (HP:0010982) | 2.15279484 |
80 | Interstitial pulmonary disease (HP:0006530) | 2.14780221 |
81 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.14227502 |
82 | Villous atrophy (HP:0011473) | 2.14227502 |
83 | Apathy (HP:0000741) | 2.13951017 |
84 | Vacuolated lymphocytes (HP:0001922) | 2.13805286 |
85 | Thin bony cortex (HP:0002753) | 2.12252596 |
86 | Growth hormone excess (HP:0000845) | 2.12165974 |
87 | Thoracic kyphosis (HP:0002942) | 2.11128686 |
88 | Abnormality of macrophages (HP:0004311) | 2.10344372 |
89 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.09727284 |
90 | Inflammation of the large intestine (HP:0002037) | 2.09004611 |
91 | Gingivitis (HP:0000230) | 2.05908222 |
92 | Severe short stature (HP:0003510) | 2.04565089 |
93 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.04293372 |
94 | Broad face (HP:0000283) | 2.03954502 |
95 | Abnormality of the thoracic spine (HP:0100711) | 2.03842707 |
96 | Abnormal number of erythroid precursors (HP:0012131) | 2.03793816 |
97 | Recurrent bacterial skin infections (HP:0005406) | 2.03275914 |
98 | Recurrent viral infections (HP:0004429) | 1.97749085 |
99 | Ankle clonus (HP:0011448) | 1.97558129 |
100 | Abnormality of the lower motor neuron (HP:0002366) | 1.96825041 |
101 | Long toe (HP:0010511) | 1.94804476 |
102 | Depression (HP:0000716) | 1.94339030 |
103 | Vertebral compression fractures (HP:0002953) | 1.93571541 |
104 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.92287072 |
105 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.92287072 |
106 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.91852525 |
107 | Seborrheic dermatitis (HP:0001051) | 1.91788951 |
108 | Achilles tendon contracture (HP:0001771) | 1.89607704 |
109 | Hypertriglyceridemia (HP:0002155) | 1.88735324 |
110 | Ragged-red muscle fibers (HP:0003200) | 1.87747480 |
111 | Hypertensive crisis (HP:0100735) | 1.87211521 |
112 | Gastrointestinal dysmotility (HP:0002579) | 1.87064358 |
113 | Germ cell neoplasia (HP:0100728) | 1.86757778 |
114 | Ketoacidosis (HP:0001993) | 1.85001486 |
115 | Foot dorsiflexor weakness (HP:0009027) | 1.84558354 |
116 | Hyporeflexia of lower limbs (HP:0002600) | 1.83525193 |
117 | Global brain atrophy (HP:0002283) | 1.82178633 |
118 | Progressive muscle weakness (HP:0003323) | 1.82089222 |
119 | Premature skin wrinkling (HP:0100678) | 1.81710749 |
120 | Gastrointestinal infarctions (HP:0005244) | 1.81314568 |
121 | Rhabdomyolysis (HP:0003201) | 1.80472655 |
122 | Striae distensae (HP:0001065) | 1.80189341 |
123 | Radial bowing (HP:0002986) | 1.79880082 |
124 | Pustule (HP:0200039) | 1.79821059 |
125 | Abnormality of T cells (HP:0002843) | 1.79597722 |
126 | Recurrent fungal infections (HP:0002841) | 1.79342940 |
127 | Personality changes (HP:0000751) | 1.79316857 |
128 | Spinal canal stenosis (HP:0003416) | 1.79157767 |
129 | Abnormality of oral frenula (HP:0000190) | 1.78983026 |
130 | Restrictive lung disease (HP:0002091) | 1.78371427 |
131 | Gout (HP:0001997) | 1.78207996 |
132 | Angiofibromas (HP:0010615) | 1.77628286 |
133 | Adenoma sebaceum (HP:0009720) | 1.77628286 |
134 | Difficulty climbing stairs (HP:0003551) | 1.77394754 |
135 | IgM deficiency (HP:0002850) | 1.77389031 |
136 | Elfin facies (HP:0004428) | 1.77352467 |
137 | Rectal prolapse (HP:0002035) | 1.76706746 |
138 | Hypoplasia of the pons (HP:0012110) | 1.76360061 |
139 | Acanthosis nigricans (HP:0000956) | 1.75985259 |
140 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.74783435 |
141 | Recurrent cutaneous fungal infections (HP:0011370) | 1.74783435 |
142 | J-shaped sella turcica (HP:0002680) | 1.74164500 |
143 | Long palpebral fissure (HP:0000637) | 1.72940641 |
144 | Myositis (HP:0100614) | 1.72228775 |
145 | Abnormality of the Achilles tendon (HP:0005109) | 1.71921000 |
146 | Abnormality of the columella (HP:0009929) | 1.71296957 |
147 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.70779155 |
148 | Peripheral hypomyelination (HP:0007182) | 1.70620182 |
149 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.70126853 |
150 | Lymphangioma (HP:0100764) | 1.69648904 |
151 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.69187226 |
152 | Limb-girdle muscle atrophy (HP:0003797) | 1.69159578 |
153 | Slow saccadic eye movements (HP:0000514) | 1.69094332 |
154 | Hypoglycemic coma (HP:0001325) | 1.68900324 |
155 | Annular pancreas (HP:0001734) | 1.68741786 |
156 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.68569907 |
157 | Failure to thrive in infancy (HP:0001531) | 1.68302503 |
158 | Chest pain (HP:0100749) | 1.66540757 |
159 | Poikiloderma (HP:0001029) | 1.66204849 |
160 | Verrucae (HP:0200043) | 1.65684167 |
161 | Papilloma (HP:0012740) | 1.65684167 |
162 | Onion bulb formation (HP:0003383) | 1.65514105 |
163 | Axonal loss (HP:0003447) | 1.65503709 |
164 | Visceral angiomatosis (HP:0100761) | 1.65109978 |
165 | Osteomyelitis (HP:0002754) | 1.64847988 |
166 | Malnutrition (HP:0004395) | 1.63940883 |
167 | Abnormality of the foot musculature (HP:0001436) | 1.63300433 |
168 | Neuronal loss in central nervous system (HP:0002529) | 1.62710161 |
169 | Prolonged bleeding time (HP:0003010) | 1.60996293 |
170 | Systemic lupus erythematosus (HP:0002725) | 1.60911844 |
171 | Urticaria (HP:0001025) | 1.60644566 |
172 | Difficulty running (HP:0009046) | 1.60170326 |
173 | Lower limb amyotrophy (HP:0007210) | 1.59417397 |
174 | Purpura (HP:0000979) | 1.58998570 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 3.95824943 |
2 | TRIB3 | 3.57799761 |
3 | PRPF4B | 3.50757401 |
4 | MAP3K10 | 2.98845725 |
5 | SMG1 | 2.91633399 |
6 | MAP3K13 | 2.60337156 |
7 | SCYL2 | 2.57155039 |
8 | PKN2 | 2.56445558 |
9 | MAP3K9 | 2.40784472 |
10 | EEF2K | 2.29262261 |
11 | MAP4K1 | 2.09357277 |
12 | BLK | 2.07338661 |
13 | TNK2 | 1.97013193 |
14 | PASK | 1.89444795 |
15 | SIK3 | 1.81186384 |
16 | INSRR | 1.74154012 |
17 | GRK6 | 1.70196098 |
18 | NME2 | 1.65517019 |
19 | KSR2 | 1.64922332 |
20 | TESK2 | 1.62113437 |
21 | FLT3 | 1.61847330 |
22 | ZAP70 | 1.55815557 |
23 | SIK2 | 1.54172692 |
24 | MAP3K7 | 1.52663115 |
25 | TBK1 | 1.51764145 |
26 | NTRK1 | 1.51083515 |
27 | CAMKK1 | 1.42890042 |
28 | SIK1 | 1.40806780 |
29 | RIPK1 | 1.37463000 |
30 | IRAK3 | 1.36243754 |
31 | DYRK1B | 1.35928832 |
32 | TAOK3 | 1.30325133 |
33 | LRRK2 | 1.26130388 |
34 | TTN | 1.25123629 |
35 | PAK4 | 1.23320983 |
36 | IRAK4 | 1.23105393 |
37 | CDK12 | 1.17381246 |
38 | DAPK1 | 1.16147911 |
39 | HIPK2 | 1.15645516 |
40 | EPHA2 | 1.14573969 |
41 | CAMKK2 | 1.08840264 |
42 | CDK19 | 1.07513365 |
43 | TYK2 | 1.06995946 |
44 | KSR1 | 1.06524037 |
45 | FGFR4 | 1.03756171 |
46 | TGFBR2 | 1.02994024 |
47 | MAP3K3 | 1.02739475 |
48 | PTK6 | 1.00038536 |
49 | MAP3K2 | 0.99749739 |
50 | MAPK12 | 0.98852672 |
51 | SYK | 0.97786677 |
52 | NEK1 | 0.97154059 |
53 | TESK1 | 0.96634060 |
54 | PDPK1 | 0.95300098 |
55 | ICK | 0.95127126 |
56 | ALK | 0.94686164 |
57 | PRKD3 | 0.93870476 |
58 | MATK | 0.93120348 |
59 | EPHB1 | 0.92210097 |
60 | MAPK15 | 0.90291685 |
61 | MARK2 | 0.89239703 |
62 | TAOK2 | 0.89089823 |
63 | MINK1 | 0.88973364 |
64 | JAK3 | 0.87985217 |
65 | RPS6KC1 | 0.87884177 |
66 | RPS6KL1 | 0.87884177 |
67 | TAOK1 | 0.86341083 |
68 | PDGFRA | 0.86146617 |
69 | DYRK3 | 0.85259800 |
70 | TYRO3 | 0.83491793 |
71 | BTK | 0.82479256 |
72 | DAPK2 | 0.81545107 |
73 | RAF1 | 0.80637724 |
74 | BCKDK | 0.80566106 |
75 | RET | 0.77644551 |
76 | KDR | 0.77330442 |
77 | MAP3K11 | 0.76962526 |
78 | MAPKAPK3 | 0.75244777 |
79 | CDC42BPA | 0.74793004 |
80 | ARAF | 0.73894901 |
81 | EPHA3 | 0.73694495 |
82 | CSF1R | 0.73144085 |
83 | PDK1 | 0.72107740 |
84 | JAK1 | 0.71969137 |
85 | JAK2 | 0.70246924 |
86 | LMTK2 | 0.69306981 |
87 | BRAF | 0.68012309 |
88 | NTRK3 | 0.67880418 |
89 | RPS6KA6 | 0.65578790 |
90 | PRKG2 | 0.65397381 |
91 | PIM2 | 0.64431473 |
92 | CSK | 0.64171096 |
93 | MAPK11 | 0.63503278 |
94 | MAP3K1 | 0.63340566 |
95 | MAP3K6 | 0.63038423 |
96 | UHMK1 | 0.61257937 |
97 | IRAK2 | 0.57950041 |
98 | BRSK1 | 0.55819167 |
99 | MAP2K3 | 0.54986676 |
100 | MAP2K2 | 0.53050221 |
101 | RPS6KA2 | 0.52906098 |
102 | PRKCI | 0.52496222 |
103 | RPS6KA4 | 0.51858556 |
104 | PTK2 | 0.51395518 |
105 | MAPK7 | 0.50454489 |
106 | PAK6 | 0.49823313 |
107 | CAMK1 | 0.49287037 |
108 | PRKCH | 0.47814964 |
109 | RIPK4 | 0.47669286 |
110 | CAMK4 | 0.47642516 |
111 | MARK3 | 0.47531786 |
112 | DAPK3 | 0.46938393 |
113 | BMX | 0.46365564 |
114 | RPS6KB2 | 0.46180894 |
115 | HCK | 0.44840934 |
116 | STK10 | 0.44159704 |
117 | MAP2K6 | 0.42812991 |
118 | PRKD2 | 0.41226672 |
119 | MAPK4 | 0.41164961 |
120 | NEK2 | 0.40557550 |
121 | CDK4 | 0.40272008 |
122 | IRAK1 | 0.39830699 |
123 | KIT | 0.39499685 |
124 | RPS6KA1 | 0.38748558 |
125 | MAP3K8 | 0.38448528 |
126 | MTOR | 0.38133851 |
127 | IKBKE | 0.37382829 |
128 | MAP3K14 | 0.37173937 |
129 | FES | 0.36652218 |
130 | MOS | 0.36343238 |
131 | PRKD1 | 0.35384331 |
132 | LCK | 0.35205495 |
133 | CAMK1D | 0.34385074 |
134 | MAPK9 | 0.34349918 |
135 | LYN | 0.33226990 |
136 | NTRK2 | 0.32925297 |
137 | ITK | 0.32863638 |
138 | STK38 | 0.32700752 |
139 | ILK | 0.32528965 |
140 | MAPKAPK2 | 0.27754158 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.86344572 |
2 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.78191098 |
3 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.22874371 |
4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.96734092 |
5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.79038971 |
6 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.77660433 |
7 | Sulfur relay system_Homo sapiens_hsa04122 | 1.77306334 |
8 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.73480318 |
9 | Lysosome_Homo sapiens_hsa04142 | 1.71615609 |
10 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.70052525 |
11 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.66214591 |
12 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.65738579 |
13 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.62815177 |
14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.54669773 |
15 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.53176188 |
16 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.52786839 |
17 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.49450376 |
18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.46689541 |
19 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.45244998 |
20 | Allograft rejection_Homo sapiens_hsa05330 | 1.45191922 |
21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.44552910 |
22 | Shigellosis_Homo sapiens_hsa05131 | 1.43257360 |
23 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.41269365 |
24 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.41089668 |
25 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.40327084 |
26 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.39971145 |
27 | Galactose metabolism_Homo sapiens_hsa00052 | 1.31950486 |
28 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.31623486 |
29 | Insulin secretion_Homo sapiens_hsa04911 | 1.30532473 |
30 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.30176784 |
31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.28692290 |
32 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.26476535 |
33 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.23920587 |
34 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.23216954 |
35 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.22583682 |
36 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.22094216 |
37 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.19959632 |
38 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.19316710 |
39 | Leishmaniasis_Homo sapiens_hsa05140 | 1.15350768 |
40 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.13953115 |
41 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.13201417 |
42 | Other glycan degradation_Homo sapiens_hsa00511 | 1.12108979 |
43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.11744958 |
44 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.11167817 |
45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.09550467 |
46 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.09269210 |
47 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.07962134 |
48 | Apoptosis_Homo sapiens_hsa04210 | 1.07772685 |
49 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.07678961 |
50 | Legionellosis_Homo sapiens_hsa05134 | 1.06330049 |
51 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.05422540 |
52 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.04424249 |
53 | Hepatitis C_Homo sapiens_hsa05160 | 1.03668699 |
54 | Thyroid cancer_Homo sapiens_hsa05216 | 1.01874000 |
55 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.01714097 |
56 | DNA replication_Homo sapiens_hsa03030 | 1.01247749 |
57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.00260116 |
58 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.98807758 |
59 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.98434806 |
60 | Bladder cancer_Homo sapiens_hsa05219 | 0.98164426 |
61 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.96254721 |
62 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.94794422 |
63 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.94716708 |
64 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.94571883 |
65 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.93764352 |
66 | Insulin resistance_Homo sapiens_hsa04931 | 0.93441017 |
67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.93043614 |
68 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.92273268 |
69 | Prion diseases_Homo sapiens_hsa05020 | 0.91838532 |
70 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.91758022 |
71 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.91005335 |
72 | Colorectal cancer_Homo sapiens_hsa05210 | 0.89295010 |
73 | Glioma_Homo sapiens_hsa05214 | 0.87989541 |
74 | Endocytosis_Homo sapiens_hsa04144 | 0.87829178 |
75 | Long-term potentiation_Homo sapiens_hsa04720 | 0.87710431 |
76 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.86720026 |
77 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86540121 |
78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.86008201 |
79 | Hepatitis B_Homo sapiens_hsa05161 | 0.85383269 |
80 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.84820881 |
81 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.83282856 |
82 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.81173561 |
83 | Pertussis_Homo sapiens_hsa05133 | 0.81009282 |
84 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.78865226 |
85 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.77445014 |
86 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.77109882 |
87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76377595 |
88 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.75922768 |
89 | HTLV-I infection_Homo sapiens_hsa05166 | 0.75479627 |
90 | Influenza A_Homo sapiens_hsa05164 | 0.74550218 |
91 | Tuberculosis_Homo sapiens_hsa05152 | 0.74536303 |
92 | Asthma_Homo sapiens_hsa05310 | 0.74209534 |
93 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.73124870 |
94 | Spliceosome_Homo sapiens_hsa03040 | 0.72531998 |
95 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.71642086 |
96 | Salmonella infection_Homo sapiens_hsa05132 | 0.71523527 |
97 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.69938903 |
98 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.69646963 |
99 | Prostate cancer_Homo sapiens_hsa05215 | 0.67739543 |
100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.66513632 |
101 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.66492322 |
102 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.66283659 |
103 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.65680424 |
104 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.64928718 |
105 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.64880805 |
106 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.64783861 |
107 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.62007939 |
108 | Alcoholism_Homo sapiens_hsa05034 | 0.61377514 |
109 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.59871356 |
110 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.59533112 |
111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.59416312 |
112 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56704058 |
113 | Measles_Homo sapiens_hsa05162 | 0.56619225 |
114 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.56428083 |
115 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.56056287 |
116 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55637641 |
117 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.54574431 |
118 | Gap junction_Homo sapiens_hsa04540 | 0.54371769 |
119 | Ribosome_Homo sapiens_hsa03010 | 0.53019266 |
120 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.52887996 |
121 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.52500602 |
122 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50716636 |
123 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.49893690 |
124 | Platelet activation_Homo sapiens_hsa04611 | 0.47694856 |
125 | Olfactory transduction_Homo sapiens_hsa04740 | 0.47129615 |
126 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.46934152 |
127 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.46285974 |
128 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.46075620 |
129 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.45773942 |
130 | Circadian entrainment_Homo sapiens_hsa04713 | 0.45575305 |
131 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.44239317 |